These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 29635048)

  • 1. Expression of kappa opioid receptors in developing rat brain - Implications for perinatal buprenorphine exposure.
    Tan KZ; Cunningham AM; Joshi A; Oei JL; Ward MC
    Reprod Toxicol; 2018 Jun; 78():81-89. PubMed ID: 29635048
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prenatal buprenorphine exposure decreases neurogenesis in rats.
    Wu CC; Hung CJ; Shen CH; Chen WY; Chang CY; Pan HC; Liao SL; Chen CJ
    Toxicol Lett; 2014 Feb; 225(1):92-101. PubMed ID: 24321744
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Species differences in the effects of the κ-opioid receptor antagonist zyklophin.
    Sirohi S; Aldrich JV; Walker BM
    Alcohol; 2016 Mar; 51():43-9. PubMed ID: 26992699
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Opioid receptor agonists may favorably affect bone mechanical properties in rats with estrogen deficiency-induced osteoporosis.
    Janas A; Folwarczna J
    Naunyn Schmiedebergs Arch Pharmacol; 2017 Feb; 390(2):175-185. PubMed ID: 27896372
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Opioid peptide receptor studies. 12. Buprenorphine is a potent and selective mu/kappa antagonist in the [35S]-GTP-gamma-S functional binding assay.
    Romero DV; Partilla JS; Zheng QX; Heyliger SO; Ni Q; Rice KC; Lai J; Rothman RB
    Synapse; 1999 Nov; 34(2):83-94. PubMed ID: 10502307
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Opioid addiction and pregnancy: perinatal exposure to buprenorphine affects myelination in the developing brain.
    Sanchez ES; Bigbee JW; Fobbs W; Robinson SE; Sato-Bigbee C
    Glia; 2008 Jul; 56(9):1017-27. PubMed ID: 18381654
    [TBL] [Abstract][Full Text] [Related]  

  • 7. BU48: a novel buprenorphine analog that exhibits delta-opioid-mediated convulsions but not delta-opioid-mediated antinociception in mice.
    Broom DC; Guo L; Coop A; Husbands SM; Lewis JW; Woods JH; Traynor JR
    J Pharmacol Exp Ther; 2000 Sep; 294(3):1195-200. PubMed ID: 10945877
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prenatal administration of buprenorphine using the osmotic minipump: a preliminary study of maternal and offspring toxicity and growth in the rat.
    Hutchings DE; Zmitrovich AC; Hamowy AS; Liu PY
    Neurotoxicol Teratol; 1995; 17(4):419-23. PubMed ID: 7565488
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Maturational alterations in constitutive activity of medial prefrontal cortex kappa-opioid receptors in Wistar rats.
    Sirohi S; Walker BM
    J Neurochem; 2015 Nov; 135(4):659-65. PubMed ID: 26257334
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of kappa opioid receptor mediated, dynorphin-stimulated [35S]GTPγS binding in mouse striatum for the evaluation of selective KOR ligands in an endogenous setting.
    Zhou L; Stahl EL; Lovell KM; Frankowski KJ; Prisinzano TE; Aubé J; Bohn LM
    Neuropharmacology; 2015 Dec; 99():131-41. PubMed ID: 26160155
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HS-599: a novel long acting opioid analgesic does not induce place-preference in rats.
    Lattanzi R; Negri L; Giannini E; Schmidhammer H; Schutz J; Improta G
    Br J Pharmacol; 2001 Sep; 134(2):441-7. PubMed ID: 11564664
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treadmill exercise alleviated prenatal buprenorphine exposure-induced depression in rats.
    Wu CC; Hung CJ; Lin SY; Wang YY; Chang CY; Chen WY; Liao SL; Raung SL; Yang CP; Chen CJ
    Neurochem Int; 2017 Nov; 110():91-100. PubMed ID: 28962922
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clorazepate affects cell surface regulation of delta and kappa opioid receptors, thereby altering buprenorphine-induced adaptation in the rat brain.
    Quentin T; Debruyne D; Lelong-Boulouard V; Poisnel G; Barre L; Coquerel A
    Brain Res; 2005 Nov; 1063(1):84-95. PubMed ID: 16269137
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Buprenorphine antinociception is abolished, but naloxone-sensitive reward is retained, in mu-opioid receptor knockout mice.
    Ide S; Minami M; Satoh M; Uhl GR; Sora I; Ikeda K
    Neuropsychopharmacology; 2004 Sep; 29(9):1656-63. PubMed ID: 15100703
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dynorphin activation of kappa opioid receptor reduces neuronal excitability in the paraventricular nucleus of mouse thalamus.
    Chen Z; Tang Y; Tao H; Li C; Zhang X; Liu Y
    Neuropharmacology; 2015 Oct; 97():259-69. PubMed ID: 26056031
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Perfluorooctane sulfonate induces neuronal and oligodendrocytic differentiation in neural stem cells and alters the expression of PPARγ in vitro and in vivo.
    Wan Ibrahim WN; Tofighi R; Onishchenko N; Rebellato P; Bose R; Uhlén P; Ceccatelli S
    Toxicol Appl Pharmacol; 2013 May; 269(1):51-60. PubMed ID: 23500012
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis, opioid receptor binding, and bioassay of naltrindole analogues substituted in the indolic benzene moiety.
    Ananthan S; Johnson CA; Carter RL; Clayton SD; Rice KC; Xu H; Davis P; Porreca F; Rothman RB
    J Med Chem; 1998 Jul; 41(15):2872-81. PubMed ID: 9667975
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Exposure to ethanol on prenatal days 19-20 increases ethanol intake and palatability in the infant rat: involvement of kappa and mu opioid receptors.
    Díaz-Cenzano E; Gaztañaga M; Gabriela Chotro M
    Dev Psychobiol; 2014 Sep; 56(6):1167-78. PubMed ID: 24037591
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Morphine sulfate concomitantly decreases neuronal differentiation and opioid receptor expression in mouse embryonic stem cells.
    Dholakiya SL; Aliberti A; Barile FA
    Toxicol Lett; 2016 Apr; 247():45-55. PubMed ID: 26877219
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of the Kappa-Opioid Receptor as a Therapeutic Target for Oligodendrocyte Remyelination.
    Mei F; Mayoral SR; Nobuta H; Wang F; Desponts C; Lorrain DS; Xiao L; Green AJ; Rowitch D; Whistler J; Chan JR
    J Neurosci; 2016 Jul; 36(30):7925-35. PubMed ID: 27466337
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.